Hengrun shares: accumulatively received performance compensation of 109 million yuan
Financial Associated Press, September 29 - Hengrun announced that recently, the company has received 109 million yuan of performance compensation from Qu Jianqiang, Qu Yitao, Lu Yaojuan, Huang Fei, Jiangyin Guangke Qiming enterprise management center partnership (limited partnership) (the "original equity transferor") and the original equity transferor has repurchased Jiangyin Guangke photoelectric precision equipment Co., Ltd. ("Guangke photoelectric") The corresponding repurchase amount of 31% equity is 18.1391 million yuan.
This text is a result of machine translation.
Related companies：
Briefing Updated 59 mins ago
· Technology
Haier invested and established a new energy technology company with a registered capital of 100 million yuan
In-depth
Healthcare, Financials
Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital
“I entered the venture capital industry in 2008. I experienced the financial crisis in 2009 and the boom of the classical venture capital model from 2011 to 2015. Having experienced many ups and downs, I believe that venture capital will tide over the tough period and usher in new opportunities.”
May 12, 2022 05:41 PM
Briefing Updated 4 hours ago
· Healthcare
Heavy bomb in the field of hypoglycemic! Lilly tirzepatide approved for listing
May 02, 2022 07:50 PM
Apr 18, 2022 09:14 PM
Apr 18, 2022 06:30 PM
Apr 11, 2022 08:42 PM
Briefing Updated 38 mins ago
· Technology
Zhao Dachun, deputy general manager of China Mobile: ensure that more than one million 5g base stations are opened before the 20th CPC National Congress
Briefing Updated 3 hours ago
· Technology
IDC: the compound growth rate of China's public cloud market is expected to be 30.9% in the next five years
Healthcare
R&D of Anti-COVID-19 Drugs is Blooming in China
Anti-epidemic stocks moved higher in early trading of the Hong Kong Stock Exchange today, with Kintor Pharma-B (Chinese: 开拓药业,09939:HK) and Shandong Xinhua Pharmaceutical (Chinese: 新华制药,00719:HK) leading the rally on the back of thriving R&D of anti-coronavirus drugs.
Updated 54 mins ago
Briefing Aug 30, 2021 09:08 PM
· Healthcare
Meinian health semi annual report: the net loss in the first half of the year was 428 million yuan, and the loss narrowed
Briefing Nov 13, 2020 10:44 AM
· Healthcare
Aikang Guobin reports two securities analysts of Guoxin Securities to China Securities Regulatory Commission
Briefing Updated 2 hours ago
· Technology
According to the financial times, the EU may plan to install solar panels on all new buildings.
See more
Read next
In-depth
In-depth
Healthcare, Financials
Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital
May 12, 2022 05:41 PM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.